Related Experiment Video
Updated: Jun 23, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process
Sulaiman K Marafie1, Fahd Al-Mulla2, Jehad Abubaker1
1Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, P.O. Box 1180, Dasman 15462, Kuwait.
Abstract:
The mammalian target of rapamycin (mTOR) is a pivotal regulator, integrating diverse environmental signals to control fundamental cellular functions, such as protein synthesis, cell growth, survival, and apoptosis. Embedded in a complex network of signaling pathways, mTOR dysregulation is implicated in the onset and progression of a range of human diseases, including metabolic disorders such as diabetes and cardiovascular diseases, as well as various cancers. mTOR also has a notable role in aging. Given its extensive biological impact, mTOR signaling is a prime therapeutic target for addressing these complex conditions. The development of mTOR inhibitors has proven advantageous in numerous research domains. This review delves into the significance of mTOR signaling, highlighting the critical components of this intricate network that contribute to disease. Additionally, it addresses the latest findings on mTOR inhibitors and their clinical implications. The review also emphasizes the importance of developing more effective next-generation mTOR inhibitors with dual functions to efficiently target the mTOR pathways. A comprehensive understanding of mTOR signaling will enable the development of effective therapeutic strategies for managing diseases associated with mTOR dysregulation.
Insights
The mammalian target of rapamycin (mTOR) pathway regulates cell functions and is crucial in diseases like cancer and diabetes. Developing dual-function mTOR inhibitors offers new therapeutic strategies for these conditions.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- The mammalian target of rapamycin (mTOR) is a central regulator of cellular processes, integrating environmental signals.
- Dysregulation of mTOR signaling is linked to metabolic disorders, cancer, cardiovascular diseases, and aging.
- mTOR signaling pathways are complex and play a critical role in numerous physiological and pathological conditions.
Purpose of the Study:
- To review the significance of mTOR signaling in human diseases.
- To highlight key components of the mTOR network involved in disease pathogenesis.
- To discuss recent advances in mTOR inhibitors and their clinical applications.
Main Methods:
- Literature review of mTOR signaling pathways and inhibitors.
- Analysis of the role of mTOR in disease development and progression.
- Examination of current and emerging therapeutic strategies targeting mTOR.
Main Results:
- mTOR signaling is implicated in protein synthesis, cell growth, survival, and apoptosis.
- mTOR pathway dysregulation is a hallmark of diabetes, cardiovascular diseases, cancer, and aging.
- mTOR inhibitors have shown therapeutic potential but require further development for enhanced efficacy.
Conclusions:
- A comprehensive understanding of mTOR signaling is essential for developing effective treatments.
- Next-generation mTOR inhibitors with dual functions are needed for efficient targeting of mTOR pathways.
- Targeting mTOR offers a promising therapeutic avenue for a range of complex human diseases.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Mitochondria
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitochondrial Membranes

